Considering the findings that the phosphorylation of CXCR4 at serine 339 may be a way to activate CXCR4 on the cells [44], our data further confirmed that CXCR4 shRNA could effectively inhibit CXCR4 function in IHCC cancers. This evidence concerns the gene CXCR4 and cancer.